Relationship between Circulating Tumor Cells, Blood Coagulation, and Urokinase‐Plasminogen‐Activator System in Early Breast Cancer Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1524-4741|21|2|155-160

ISSN： 1075-122x

Source： THE BREAST JOURNAL, Vol.21, Iss.2, 2015-03, pp. : 155-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Plasminogen Activator System and Cancer

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 184-194

Karger

Access to resources Recommend Favorite

Detection of Circulating Tumor Cells in Peripheral Blood of Breast Cancer Patients During or After Therapy Using a Multigene Real-Time RT-PCR Assay

By Zehentner Barbara K.  

Molecular Diagnosis & Therapy, Vol. 10, Iss. 1, 2006-01 ,pp. : 41-47

Adis International

Access to resources Recommend Favorite

Circulating Levels of Urokinase-Type Plasminogen Activator (uPA) and its Soluble Receptor (suPAR) in Patients with Atopic Eczema/Dermatitis Syndrome

By Kasperska-Zajac Alicja   Rogala Barbara  

Inflammation, Vol. 29, Iss. 2-3, 2005-06 ,pp. : 90-93

Springer Publishing Company

Access to resources Recommend Favorite

Urokinase Plasminogen Activator Colocalizes with CD25+ Cells in Atherosclerotic Vessels

By  

Journal of Vascular Research, Vol. 35, Iss. 5, 1998-10 ,pp. : 318-324

Karger

Access to resources Recommend Favorite

Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions

By  

Oncology, Vol. 76, Iss. 6, 2009-04 ,pp. : 375-386

Karger

Access to resources Recommend Favorite